VALID TRIAL
Both CHIA and your personal trial have the following criteria:
╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                                  │ CHIA Criteria                                      │   Score │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╪═════════╡
│ sign the informed consent form                     │ sign the informed consent form                     │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ the legal guardians participate in all the planned │ the legal guardians participate in all the planned │     100 │
│ follow-up and be able to comply with all research  │ follow-up and be able to comply with all research  │         │
│ procedures                                         │ procedures                                         │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ the subjects have completed the basic immunization │ the subjects have completed the basic immunization │     100 │
│ of 2 needle recombinant hepatitis B vaccine, there │ of 2 needle recombinant hepatitis B vaccine, there │         │
│ is no inoculation history of EV71 vaccine, and no  │ is no inoculation history of EV71 vaccine, and no  │         │
│ history of EV71 infection                          │ history of EV71 infection                          │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ sign the informed consent form                     │ sign the informed consent form                     │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ the legal guardians participate in all the planned │ the legal guardians participate in all the planned │     100 │
│ follow-up and be able to comply with all research  │ follow-up and be able to comply with all research  │         │
│ procedures                                         │ procedures                                         │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ there is no inoculation history of EV71 vaccine,   │ there is no inoculation history of EV71 vaccine,   │     100 │
│ and there is no history of EV71 infection          │ and there is no history of EV71 infection          │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ sign the informed consent form                     │ sign the informed consent form                     │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ the legal guardians participate in all the planned │ the legal guardians participate in all the planned │     100 │
│ follow-up and be able to comply with all research  │ follow-up and be able to comply with all research  │         │
│ procedures                                         │ procedures                                         │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ there is no inoculation history of EV71 vaccine,   │ there is no inoculation history of EV71 vaccine,   │     100 │
│ and there is no history of EV71 infection          │ and there is no history of EV71 infection          │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ sign the informed consent form                     │ sign the informed consent form                     │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ the legal guardians participate in all the planned │ the legal guardians participate in all the planned │     100 │
│ follow-up and be able to comply with all research  │ follow-up and be able to comply with all research  │         │
│ procedures                                         │ procedures                                         │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ there is no inoculation history of EV71 vaccine,   │ there is no inoculation history of EV71 vaccine,   │     100 │
│ and there is no history of EV71 infection          │ and there is no history of EV71 infection          │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ the history or family history of anaphylaxis,      │ the history or family history of anaphylaxis,      │     100 │
│ convulsion, epilepsy, encephalopathy and psychosis │ convulsion, epilepsy, encephalopathy and psychosis │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ the history of severe inoculation allergies        │ the history of severe inoculation allergies        │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ patients with immunodeficiency and malignant       │ patients with immunodeficiency and malignant       │     100 │
│ tumors during the treatment period, receiving      │ tumors during the treatment period, receiving      │         │
│ immunosuppressive therapy (oral steroid) or HIV    │ immunosuppressive therapy (oral steroid) or HIV    │         │
│ due to low immunity, or family members have        │ due to low immunity, or family members have        │         │
│ congenital immune disease                          │ congenital immune disease                          │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Nonspecific immunoglobulin was injected within one │ Nonspecific immunoglobulin was injected within one │     100 │
│ month                                              │ month                                              │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ the history of thrombocytopenia or other           │ the history of thrombocytopenia or other           │     100 │
│ thrombocytopenia with a definite diagnosis         │ thrombocytopenia with a definite diagnosis         │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ respiratory disease, acute infection or chronic    │ respiratory disease, acute infection or chronic    │     100 │
│ disease activity period                            │ disease activity period                            │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ severe cardiovascular disease, liver and kidney    │ severe cardiovascular disease, liver and kidney    │     100 │
│ disease, and complications of diabetes             │ disease, and complications of diabetes             │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ infectious, suppurative and allergic dermatosis    │ infectious, suppurative and allergic dermatosis    │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ other conditions that may affect the evaluation of │ other conditions that may affect the evaluation of │     100 │
│ the trail                                          │ the trail                                          │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ any serious adverse events that have a causal      │ any serious adverse events that have a causal      │     100 │
│ relationship with the inoculation of the upper     │ relationship with the inoculation of the upper     │         │
│ dose of the vaccine                                │ dose of the vaccine                                │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ the abnormality of 4 levels (local, systemic       │ the abnormality of 4 levels (local, systemic       │     100 │
│ adverse reactions and vital signs) was judged to   │ adverse reactions and vital signs) was judged to   │         │
│ be related to vaccination                          │ be related to vaccination                          │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ other new standards of exclusion criteria for      │ other new standards of exclusion criteria for      │     100 │
│ first needle                                       │ first needle                                       │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ other conditions that may affect the evaluation of │ other conditions that may affect the evaluation of │     100 │
│ the trail                                          │ the trail                                          │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ temperature≥37.1℃ and infectious diseases          │ temperature=37.1<U+2103> and infectious diseases   │      88 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ aged ≥ 6 months                                    │ aged = 6 months                                    │      93 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ aged ≥ 6 months                                    │ aged = 6 months                                    │      93 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ aged ≥ 8 months                                    │ aged = 8 months                                    │      93 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ aged ≥ 8 months                                    │ aged = 8 months                                    │      93 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ the last vaccination intervals ≥ 14 days           │ the last vaccination intervals = 14 days           │      98 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ the last vaccination intervals ≥ 14 days           │ the last vaccination intervals = 14 days           │      98 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ the last vaccination intervals ≥ 14 days and the   │ the last vaccination intervals = 14 days and the   │      98 │
│ last attenuated live vaccine intervals≥28days      │ last attenuated live vaccine intervals=28days      │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ the last vaccination intervals ≥ 14 days and the   │ the last vaccination intervals = 14 days and the   │      98 │
│ last attenuated live vaccine intervals ≥ 28 days   │ last attenuated live vaccine intervals = 28 days   │         │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╧═════════╛

Only your personal trial has the following criteria:
╒════════════════════════════════════════════════════╤═══════════════════════════════════════════════╤═════════╕
│ Personal Criteria                                  │ CHIA Criteria                                 │   Score │
╞════════════════════════════════════════════════════╪═══════════════════════════════════════════════╪═════════╡
│ Must have maximum age of 12 Months                 │ aged = 6 months                               │      45 │
├────────────────────────────────────────────────────┼───────────────────────────────────────────────┼─────────┤
│ Inclusion criteria for group                       │ other new standards of exclusion criteria for │      46 │
│ Ⅱ（MPSV-A:1+EV71）were as follows                  │ first needle                                  │         │
├────────────────────────────────────────────────────┼───────────────────────────────────────────────┼─────────┤
│ Inclusion criteria for group Ⅰ（HepB:3+EV71）were  │ other new standards of exclusion criteria for │      47 │
│ as follows                                         │ first needle                                  │         │
├────────────────────────────────────────────────────┼───────────────────────────────────────────────┼─────────┤
│ Inclusion criteria for group Ⅳ（JE-L+EV71）were as │ other new standards of exclusion criteria for │      47 │
│ follows                                            │ first needle                                  │         │
├────────────────────────────────────────────────────┼───────────────────────────────────────────────┼─────────┤
│ Inclusion criteria for group Ⅲ（MR+EV71）were as   │ other new standards of exclusion criteria for │      48 │
│ follows                                            │ first needle                                  │         │
├────────────────────────────────────────────────────┼───────────────────────────────────────────────┼─────────┤
│ Must have minimum age of 6 Months                  │ aged = 6 months                               │      50 │
├────────────────────────────────────────────────────┼───────────────────────────────────────────────┼─────────┤
│ Exclusion criteria for follow-up needle            │ other new standards of exclusion criteria for │      62 │
│                                                    │ first needle                                  │         │
├────────────────────────────────────────────────────┼───────────────────────────────────────────────┼─────────┤
│ temperature ≤ 37℃                                  │ temperature = 37<U+2103>                      │      73 │
├────────────────────────────────────────────────────┼───────────────────────────────────────────────┼─────────┤
│ temperature ≤ 37℃                                  │ temperature = 37<U+2103>                      │      73 │
├────────────────────────────────────────────────────┼───────────────────────────────────────────────┼─────────┤
│ temperature ≤ 37℃                                  │ temperature = 37<U+2103>                      │      73 │
├────────────────────────────────────────────────────┼───────────────────────────────────────────────┼─────────┤
│ temperature ≤ 37℃                                  │ temperature = 37<U+2103>                      │      73 │
├────────────────────────────────────────────────────┼───────────────────────────────────────────────┼─────────┤
│ Exclusion criteria for first needle                │ other new standards of exclusion criteria for │      73 │
│                                                    │ first needle                                  │         │
╘════════════════════════════════════════════════════╧═══════════════════════════════════════════════╧═════════╛

Only CHIA has the following criteria:
╒═════════════════════╤══════════════════════════╤═════════╕
│ Personal Criteria   │ CHIA Criteria            │   Score │
╞═════════════════════╪══════════════════════════╪═════════╡
│ temperature ≤ 37℃   │ temperature = 37<U+2103> │      73 │
├─────────────────────┼──────────────────────────┼─────────┤
│ temperature ≤ 37℃   │ temperature = 37<U+2103> │      73 │
├─────────────────────┼──────────────────────────┼─────────┤
│ temperature ≤ 37℃   │ temperature = 37<U+2103> │      73 │
├─────────────────────┼──────────────────────────┼─────────┤
│ temperature ≤ 37℃   │ temperature = 37<U+2103> │      73 │
╘═════════════════════╧══════════════════════════╧═════════╛

Levenshtein Ratio of Entire trial at once: 92
Average Levenshtein Ratio of individual lines: 87.08
OverAll Ratio: 89.53999999999999
